BMO Capital Markets upgraded shares of Extendicare (TSE:EXE – Free Report) to a hold rating in a research report released on Tuesday morning,Zacks.com reports.
A number of other brokerages have also recently commented on EXE. TD Securities increased their price target on shares of Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research report on Thursday, November 14th. Royal Bank of Canada boosted their price target on shares of Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a report on Thursday, November 28th.
Check Out Our Latest Stock Analysis on EXE
Extendicare Stock Up 0.8 %
Extendicare (TSE:EXE – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share for the quarter. Extendicare had a return on equity of 60.00% and a net margin of 4.28%. During the same period in the prior year, the company posted $0.13 EPS. On average, sell-side analysts forecast that Extendicare will post 0.6134729 earnings per share for the current year.
Extendicare Announces Dividend
The firm also recently announced a monthly dividend, which will be paid on Friday, February 14th. Investors of record on Friday, February 14th will be issued a dividend of $0.04 per share. This represents a $0.48 annualized dividend and a yield of 4.60%. The ex-dividend date of this dividend is Friday, January 31st. Extendicare’s payout ratio is 70.59%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- How to Read Stock Charts for Beginners
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Using the MarketBeat Dividend Yield Calculator
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What Are Dividend Contenders? Investing in Dividend Contenders
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.